Article
Interferon-γ inducible protein-10 and interleukin 28B gene polymorphism as predictive markers for genotype 4 hepatitis C virus treatment response.
Tropical biomedicine - 1 Dec 2020
Abd El-Maksoud E, Salem A M, Maher A M, Hegazy M G A
Abstract excerpt
HCV genotype 4 dominates the HCV epidemic in Egypt. Drug resistance was the most serious side effect that reflects bad clinical outcome. Several studies had demonstrated that baseline serum interferon-γ-inducible-protein 10 (IP-10) levels and interleukin 28B polymorphisms were associated with the resistance to the standard of care pegylated interferon alpha and ribavirin (PEG-IFNα/RBV) therapy and development of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
